TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 33 filers reported holding TITAN PHARMACEUTICALS INC DE in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $6,000 | 0.0% | 28,073 | 0.0% | 0.00% | – |
| Q3 2018 | $6,000 | -80.6% | 28,073 | 0.0% | 0.00% | – |
| Q2 2018 | $31,000 | +6.9% | 28,073 | 0.0% | 0.00% | – |
| Q1 2018 | $29,000 | -21.6% | 28,073 | 0.0% | 0.00% | – |
| Q4 2017 | $37,000 | -24.5% | 28,073 | 0.0% | 0.00% | – |
| Q3 2017 | $49,000 | -7.5% | 28,073 | 0.0% | 0.00% | – |
| Q2 2017 | $53,000 | -43.0% | 28,073 | 0.0% | 0.00% | – |
| Q1 2017 | $93,000 | -17.0% | 28,073 | 0.0% | 0.00% | – |
| Q4 2016 | $112,000 | -32.1% | 28,073 | 0.0% | 0.00% | – |
| Q3 2016 | $165,000 | +7.1% | 28,073 | 0.0% | 0.00% | – |
| Q2 2016 | $154,000 | +14.9% | 28,073 | 0.0% | 0.00% | – |
| Q1 2016 | $134,000 | +7.2% | 28,073 | +0.0% | 0.00% | – |
| Q4 2015 | $125,000 | – | 28,072 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acrospire Investment Management LLC | 22,670 | $75,000 | 0.06% |
| Wealthspire Advisors, L.P. | 11,708 | $39,000 | 0.01% |
| THOMPSON DAVIS & CO., INC. | 1,091 | $4,000 | 0.01% |
| Blume Capital Management, Inc. | 2,546 | $8,000 | 0.01% |
| Westside Investment Management, Inc. | 2,862 | $9,159,000 | 0.00% |
| BLUESTEIN R H & CO LLC | 22,000 | $73,000 | 0.00% |
| ARCADIA INVESTMENT MANAGEMENT CORP/MI | 1,819 | $6,000 | 0.00% |
| STRS OHIO | 107,400 | $354,000 | 0.00% |
| Parallax Volatility Advisers, L.P. | 80,000 | $264,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,946 | $13,000 | 0.00% |